MA
MCF Advisors Portfolio holdings
AUM
$1.51B
1-Year Return
11.12%
This Quarter Return
-0.73%
1 Year Return
+11.12%
3 Year Return
+41.11%
5 Year Return
+65.13%
10 Year Return
+108.06%
AUM
$1.42B
AUM Growth
-$1.01M
(-0.07%)
Cap. Flow
+$13.9M
Cap. Flow
% of AUM
0.97%
Top 10 Holdings %
Top 10 Hldgs %
67.23%
Holding
1,059
New
54
Increased
253
Reduced
201
Closed
67
Top Buys
Top Sells
| 1 |
Vanguard S&P 500 ETF
VOO
|
$23.9M |
| 2 |
IBDP
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
|
$9.27M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
$5.21M |
| 4 |
PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
|
$1.96M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
$1.5M |
Sector Composition
| 1 | Technology | 4.43% |
| 2 | Financials | 2.69% |
| 3 | Healthcare | 1.3% |
| 4 | Industrials | 1.24% |
| 5 | Consumer Discretionary | 1.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Parker-Hannifin
PH
$96.1B
| $89.8K | 0.01% |
141
-994
| -88% | -$633K |
|
327
BP
BP
$87.4B
| $89.7K | 0.01% |
3,034
+11
| +0.4% | +$325 |
|
328
Hertz
HTZ
$1.7B
| $89.2K | 0.01% |
24,376
| – | – |
|
329
Amphenol
APH
$135B
| $87.2K | 0.01% |
1,252
-15
| -1% | -$1.04K |
|
330
Xylem
XYL
$34.2B
| $87K | 0.01% |
750
-3
| -0.4% | -$348 |
|
331
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $85K | 0.01% |
1,778
+19
| +1% | +$909 |
|
332
DNP Select Income Fund
DNP
$3.67B
| $84.8K | 0.01% |
9,619
| – | – |
|
333
CME Group
CME
$94.4B
| $84.7K | 0.01% |
358
+73
| +26% | +$17.3K |
|
334
Symbotic
SYM
$5.37B
| $84.5K | 0.01% |
+3,564
| New | +$84.5K |
|
335
T-Mobile US
TMUS
$284B
| $84K | 0.01% |
381
| – | – |
|
336
Prudential Financial
PRU
$37.2B
| $83.1K | 0.01% |
701
-19
| -3% | -$2.25K |
|
337
Arm
ARM
$146B
| $82.8K | 0.01% |
+671
| New | +$82.8K |
|
338
Packaging Corp of America
PKG
$19.8B
| $82.3K | 0.01% |
365
+5
| +1% | +$1.13K |
|
339
iShares 3-7 Year Treasury Bond ETF
IEI
$16.8B
| $81.3K | 0.01% |
704
| – | – |
|
340
Global X MLP & Energy Infrastructure ETF
MLPX
$2.56B
| $81.3K | 0.01% |
1,341
| – | – |
|
341
Cal-Maine
CALM
$5.52B
| $80.9K | 0.01% |
786
| – | – |
|
342
CRISPR Therapeutics
CRSP
$4.99B
| $80.2K | 0.01% |
+2,037
| New | +$80.2K |
|
343
iShares Biotechnology ETF
IBB
$5.8B
| $79.3K | 0.01% |
600
| – | – |
|
344
Schwab US REIT ETF
SCHH
$8.38B
| $78.8K | 0.01% |
3,744
+3,388
| +952% | +$71.4K |
|
345
Arthur J. Gallagher & Co
AJG
$76.7B
| $78.6K | 0.01% |
277
+5
| +2% | +$1.42K |
|
346
Salesforce
CRM
$239B
| $77.3K | 0.01% |
231
+90
| +64% | +$30.1K |
|
347
Vulcan Materials
VMC
$39B
| $76.8K | 0.01% |
299
+24
| +9% | +$6.17K |
|
348
EOG Resources
EOG
$64.4B
| $76.6K | 0.01% |
625
+193
| +45% | +$23.7K |
|
349
Consumers Staples Select Sector SPDR Fund
XLP
$15.8B
| $76.2K | 0.01% |
970
-16
| -2% | -$1.26K |
|
350
Newmont
NEM
$83.7B
| $76.2K | 0.01% |
2,048
-785
| -28% | -$29.2K |
|